1. Home
  2. BWLP vs EVO Comparison

BWLP vs EVO Comparison

Compare BWLP & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BW LPG Limited

BWLP

BW LPG Limited

HOLD

Current Price

$12.49

Market Cap

1.8B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.93

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWLP
EVO
Founded
1935
1993
Country
Singapore
Germany
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BWLP
EVO
Price
$12.49
$2.93
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
418.1K
238.0K
Earning Date
12-02-2025
11-05-2025
Dividend Yield
10.55%
N/A
EPS Growth
N/A
N/A
EPS
1.14
N/A
Revenue
$3,693,482,000.00
$887,396,457.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.24
$8.80
P/E Ratio
$11.18
N/A
Revenue Growth
2.54
N/A
52 Week Low
$7.86
$2.84
52 Week High
$16.60
$5.10

Technical Indicators

Market Signals
Indicator
BWLP
EVO
Relative Strength Index (RSI) 49.10 38.55
Support Level $11.99 $2.94
Resistance Level $12.65 $3.05
Average True Range (ATR) 0.27 0.10
MACD 0.05 0.01
Stochastic Oscillator 71.96 18.67

Price Performance

Historical Comparison
BWLP
EVO

About BWLP BW LPG Limited

BW LPG Ltd is an LPG shipping. It uses pioneering technology to power its vessels with cleaner-burning liquefied petroleum gas (LPG) and invest in R&D to take towards a zero-carbon future. The company is organized into two main segments: The shipping segment and the product services segment which buy and sell liquid petroleum gas and deliver it to customers. It generates the majority of its revenue from the shipping segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: